Saturday, February 22, 2025
spot_img

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) — Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that Jake Elguicze, embecta’s Chief Financial Officer, will present at the J.P. Morgan Global Leveraged Finance Conference in Miami on Tuesday, February 25, 2025 at 3:00 p.m. ET.

About embecta
embecta is a global diabetes care company that is leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts: 

Media
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Contact Media Relations
Investors 
Pravesh Khandelwal
VP, Head of Investor Relations
551-264-6547 
Contact IR

Powered by SlickText.com

Hot this week

The Marketing Alliance Announces Financial Results for Quarter Ended December 31, 2024

ST. LOUIS, Feb. 21, 2025 (GLOBE NEWSWIRE)...

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results

Fourth quarter 2024 CAPLYTA net product sales grew to...

Faircourt Asset Management Inc. Announces February Distribution

Toronto, Feb. 21, 2025 (GLOBE NEWSWIRE) --...

Topics

spot_img

Related Articles

Popular Categories

spot_img